
| Delaware | 27-1605762 | |||||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||
39899 Balentine Drive, Suite 235, Newark, California | 94560 | |||||||
| (Address of principal executive offices) | (Zip Code) | |||||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
| Common Stock, par value $0.0001 per share | CNXC | The Nasdaq Stock Market LLC | ||||||
| Page | ||||||||
| Announcement Date | Record Date | Per Share Dividend Amount | Payment Date | ||||||||
| January 24, 2024 | February 5, 2024 | $0.3025 | February 15, 2024 | ||||||||
| March 26, 2024 | April 26, 2024 | $0.3025 | May 7, 2024 | ||||||||
| June 26, 2024 | July 26, 2024 | $0.3025 | August 6, 2024 | ||||||||
| September 25, 2024 | October 25, 2024 | $0.33275 | November 5, 2024 | ||||||||
| January 15, 2025 | January 31, 2025 | $0.33275 | February 11, 2025 | ||||||||
| March 26, 2025 | April 25, 2025 | $0.33275 | May 6, 2025 | ||||||||
| June 26, 2025 | July 25, 2025 | $0.33275 | August 5, 2025 | ||||||||
| September 25, 2025 | October 24, 2025 | $0.36 | November 4, 2025 | ||||||||
| Period | Total number of shares purchased (1) (2) | Average price paid per share | Total number of shares purchased as part of publicly announced program(2) | Maximum dollar amount that may yet be purchased under the program (in thousands)(3) | ||||||||||
| September 1, 2025 - September 30, 2025 | 267,252 | $ | 53.23 | 264,597 | $ | 481,318 | ||||||||
| October 1, 2025 - October 31, 2025 | 787,716 | $ | 46.10 | 434,858 | $ | 461,270 | ||||||||
| November 1, 2025 - November 30, 2025 | 610,044 | $ | 35.75 | 609,882 | $ | 439,468 | ||||||||
| Total | 1,665,012 | $ | 43.35 | 1,309,337 | ||||||||||

| December 1, 2020 | November 30, 2021 | November 30, 2022 | November 30, 2023 | November 30, 2024 | November 30, 2025 | |||||||||||||||
| Concentrix Corporation | $ | 100.00 | $ | 158.10 | $ | 116.55 | $ | 89.51 | $ | 42.81 | $ | 36.89 | ||||||||
| S&P Midcap 400 | $ | 100.00 | $ | 123.43 | $ | 117.47 | $ | 116.82 | $ | 153.39 | $ | 164.58 | ||||||||
| Peer Group | $ | 100.00 | $ | 121.30 | $ | 72.41 | $ | 35.76 | $ | 26.18 | $ | 25.83 | ||||||||
| Fiscal Years Ended November 30, | |||||||||||
| 2025 | 2024 | ||||||||||
| (in thousands) | |||||||||||
| Revenue | $ | 9,825,771 | $ | 9,618,900 | |||||||
| Cost of revenue | 6,390,760 | 6,170,013 | |||||||||
| Gross profit | 3,435,011 | 3,448,887 | |||||||||
| Selling, general and administrative expenses | 2,825,468 | 2,852,500 | |||||||||
| Impairment charges | 1,527,726 | — | |||||||||
| Operating income (loss) | (918,183) | 596,387 | |||||||||
| Interest expense and finance charges, net | 290,349 | 321,828 | |||||||||
| Other income, net | (26,310) | (24,715) | |||||||||
| Income (loss) before income taxes | (1,182,222) | 299,274 | |||||||||
| Provision for income taxes | 96,702 | 48,057 | |||||||||
| Net income (loss) | $ | (1,278,924) | $ | 251,217 | |||||||
| Fiscal Years Ended November 30, | Percent Change | ||||||||||||||||
| 2025 | 2024 | 2025 to 2024 | |||||||||||||||
| (in thousands) | |||||||||||||||||
| Industry vertical: | |||||||||||||||||
| Technology and consumer electronics | $ | 2,666,072 | $ | 2,674,040 | (0.3) | % | |||||||||||
Retail, travel and e-commerce | 2,433,885 | 2,361,866 | 3.0 | % | |||||||||||||
| Communications and media | 1,592,373 | 1,527,922 | 4.2 | % | |||||||||||||
| Banking, financial services and insurance | 1,536,223 | 1,455,641 | 5.5 | % | |||||||||||||
| Healthcare | 725,283 | 727,389 | (0.3) | % | |||||||||||||
| Other | 871,935 | 872,042 | 0.0 | % | |||||||||||||
| Total | $ | 9,825,771 | $ | 9,618,900 | 2.2 | % | |||||||||||
| Fiscal Years Ended November 30, | Percent Change | ||||||||||||||||
| 2025 | 2024 | 2025 to 2024 | |||||||||||||||
| ($ in thousands) | |||||||||||||||||
Cost of revenue | $ | 6,390,760 | $ | 6,170,013 | 3.6 | % | |||||||||||
Gross profit | $ | 3,435,011 | $ | 3,448,887 | (0.4) | % | |||||||||||
Gross margin % | 35.0 | % | 35.9 | % | |||||||||||||
| Fiscal Years Ended November 30, | Percent Change | ||||||||||||||||
| 2025 | 2024 | 2025 to 2024 | |||||||||||||||
| ($ in thousands) | |||||||||||||||||
Selling, general and administrative expenses | $ | 2,825,468 | $ | 2,852,500 | (0.9) | % | |||||||||||
Percentage of revenue | 28.8 | % | 29.7 | % | |||||||||||||
| Fiscal Years Ended November 30, | Percent Change | ||||||||||||||||
| 2025 | 2024 | 2025 to 2024 | |||||||||||||||
| ($ in thousands) | |||||||||||||||||
Impairment charges | $ | 1,527,726 | $ | — | NM | ||||||||||||
Percentage of revenue | 15.5 | % | 0.0 | % | |||||||||||||
| Fiscal Years Ended November 30, | Percent Change | ||||||||||||||||
| 2025 | 2024 | 2025 to 2024 | |||||||||||||||
| ($ in thousands) | |||||||||||||||||
Operating income (loss) | $ | (918,183) | $ | 596,387 | NM | ||||||||||||
Operating margin | (9.3) | % | 6.2 | % | |||||||||||||
| Fiscal Years Ended November 30, | Percent Change | ||||||||||||||||
| 2025 | 2024 | 2025 to 2024 | |||||||||||||||
| ($ in thousands) | |||||||||||||||||
Interest expense and finance charges, net | $ | 290,349 | $ | 321,828 | (9.8) | % | |||||||||||
Percentage of revenue | 3.0 | % | 3.3 | % | |||||||||||||
| Fiscal Years Ended November 30, | Percent Change | ||||||||||||||||
| 2025 | 2024 | 2025 to 2024 | |||||||||||||||
| ($ in thousands) | |||||||||||||||||
Other income, net | $ | (26,310) | $ | (24,715) | 6.5 | % | |||||||||||
Percentage of revenue | (0.3) | % | (0.3) | % | |||||||||||||
| Fiscal Years Ended November 30, | Percent Change | ||||||||||||||||
| 2025 | 2024 | 2025 to 2024 | |||||||||||||||
| ($ in thousands) | |||||||||||||||||
Provision for income taxes | $ | 96,702 | $ | 48,057 | 101.2 | % | |||||||||||
Percentage of income before income taxes | (8.2) | % | 16.1 | % | |||||||||||||
| Fiscal Years Ended November 30, | |||||||||||
| 2025 | 2024 | ||||||||||
| ($ in thousands except per share amounts) | |||||||||||
Operating income (loss) | $ | (918,183) | $ | 596,387 | |||||||
Impairment charges | 1,527,726 | — | |||||||||
Acquisition-related, integration and restructuring expenses(1) | 101,468 | 156,771 | |||||||||
Step-up depreciation | 10,326 | 9,907 | |||||||||
Amortization of intangibles | 434,332 | 458,925 | |||||||||
Share-based compensation | 97,875 | 95,922 | |||||||||
| Non-GAAP operating income | $ | 1,253,544 | $ | 1,317,912 | |||||||
Net income (loss) | $ | (1,278,924) | $ | 251,217 | |||||||
Interest expense and finance charges, net | 290,349 | 321,828 | |||||||||
Provision for income taxes | 96,702 | 48,057 | |||||||||
Other income, net | (26,310) | (24,715) | |||||||||
Impairment charges | 1,527,726 | — | |||||||||
Acquisition-related, integration and restructuring expenses(1) | 101,468 | 156,771 | |||||||||
Step-up depreciation | 10,326 | 9,907 | |||||||||
Amortization of intangibles | 434,332 | 458,925 | |||||||||
Share-based compensation | 97,875 | 95,922 | |||||||||
Depreciation (exclusive of step-up depreciation) | 215,775 | 237,013 | |||||||||
| Adjusted EBITDA | $ | 1,469,319 | $ | 1,554,925 | |||||||
| Operating margin | (9.3) | % | 6.2 | % | |||||||
| Non-GAAP operating margin | 12.8 | % | 13.7 | % | |||||||
| Adjusted EBITDA margin | 15.0 | % | 16.2 | % | |||||||
Net income (loss) | $ | (1,278,924) | $ | 251,217 | |||||||
Impairment charges | 1,527,726 | — | |||||||||
Acquisition-related and integration expenses (1) | 101,468 | 156,771 | |||||||||
Step-up depreciation | 10,326 | 9,907 | |||||||||
Debt costs (2) | 1,323 | — | |||||||||
Imputed interest related to Sellers’ Note included in interest expense and finance charges, net | 14,577 | 16,895 | |||||||||
Legal settlement costs (3) | 2,000 | — | |||||||||
Change in acquisition contingent consideration included in other income, net | (1,958) | (29,268) | |||||||||
Foreign currency gains, net (4) | (28,959) | (1,850) | |||||||||
| Amortization of intangibles | 434,332 | 458,925 | |||||||||
| Share-based compensation | 97,875 | 95,922 | |||||||||
Income taxes related to the above (5) | (155,034) | (173,963) | |||||||||
Income tax effect of change in tax law | 5,699 | — | |||||||||
Income tax effect of legal entity restructuring | 12,960 | (12,254) | |||||||||
| Non-GAAP net income | $ | 743,411 | $ | 772,302 | |||||||
| Fiscal Year Ended | |||||||||||
| November 30, 2025 | November 30, 2024 | ||||||||||
Diluted earnings (loss) per common share (“EPS”) | $ | (20.36) | $ | 3.71 | |||||||
| Impairment charges | 24.22 | — | |||||||||
Acquisition-related, integration and restructuring expenses (1) | 1.61 | 2.41 | |||||||||
| Step-up depreciation | 0.16 | 0.15 | |||||||||
Debt costs (2) | 0.02 | — | |||||||||
Imputed interest related to Sellers’ Note included in interest expense and finance charges, net | 0.23 | 0.26 | |||||||||
Legal settlement costs (3) | 0.03 | — | |||||||||
Change in acquisition contingent consideration included in other income, net | (0.03) | (0.45) | |||||||||
Foreign currency gains, net (4) | (0.46) | (0.03) | |||||||||
| Amortization of intangibles | 6.89 | 7.05 | |||||||||
| Share-based compensation | 1.55 | 1.47 | |||||||||
Income taxes related to the above (5) | (2.46) | (2.67) | |||||||||
| Income tax effect of change in tax law | 0.09 | — | |||||||||
| Income tax effect of legal entity restructuring | 0.21 | (0.19) | |||||||||
| Adjustment for participating securities | (0.48) | (0.29) | |||||||||
| Non-GAAP Diluted EPS | $ | 11.22 | $ | 11.42 | |||||||
| Announcement Date | Record Date | Per Share Dividend Amount | Payment Date | ||||||||
| January 24, 2024 | February 5, 2024 | $0.3025 | February 15, 2024 | ||||||||
| March 26, 2024 | April 26, 2024 | $0.3025 | May 7, 2024 | ||||||||
| June 26, 2024 | July 26, 2024 | $0.3025 | August 6, 2024 | ||||||||
| September 25, 2024 | October 25, 2024 | $0.33275 | November 5, 2024 | ||||||||
| January 15, 2025 | January 31, 2025 | $0.33275 | February 11, 2025 | ||||||||
| March 26, 2025 | April 25, 2025 | $0.33275 | May 6, 2025 | ||||||||
| June 26, 2025 | July 25, 2025 | $0.33275 | August 5, 2025 | ||||||||
| September 25, 2025 | October 24, 2025 | $0.36 | November 4, 2025 | ||||||||
| Fiscal Years Ended November 30, | |||||||||||
| 2025 | 2024 | ||||||||||
($ in thousands) | |||||||||||
Net cash provided by operating activities | $ | 806,967 | $ | 667,492 | |||||||
Net cash used in investing activities | (250,383) | (244,266) | |||||||||
Net cash used in financing activities | (491,443) | (492,532) | |||||||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash | 26,382 | (17,577) | |||||||||
Net increase (decrease) in cash, cash equivalents and restricted cash | $ | 91,523 | $ | (86,883) | |||||||
Cash, cash equivalents and restricted cash at beginning of year | 429,604 | 516,487 | |||||||||
Cash, cash equivalents and restricted cash at end of year | $ | 521,127 | $ | 429,604 | |||||||
| Fiscal Years Ended November 30, | |||||||||||
| 2025 | 2024 | ||||||||||
($ in thousands) | |||||||||||
Net cash provided by operating activities | $ | 806,967 | $ | 667,492 | |||||||
Purchases of property and equipment | (234,496) | (238,762) | |||||||||
Free cash flow (a non-GAAP measure) | $ | 572,471 | $ | 428,730 | |||||||
Change in outstanding factoring balances | 53,933 | 45,788 | |||||||||
Adjusted free cash flow (a non-GAAP measure) | $ | 626,404 | $ | 474,518 | |||||||
| Payments Due by Period | |||||||||||||||||||||||||||||
| Total | Less than 1 Year | 1 - 3 Years | 3 - 5 Years | >5 Years | |||||||||||||||||||||||||
| (in thousands) | |||||||||||||||||||||||||||||
| Certain Contractual Obligations: | |||||||||||||||||||||||||||||
Interest on financing agreements (a) | $ | 777,061 | $ | 259,531 | $ | 308,948 | $ | 108,115 | $ | 100,467 | |||||||||||||||||||
Defined benefit plan funding (b) | 68,832 | — | 3,769 | 5,972 | 59,091 | ||||||||||||||||||||||||
| Page | |||||
| Audited Consolidated Financial Statements of Concentrix Corporation: | |||||
Report of Independent Registered Public Accounting Firm (PCAOB ID: 185) | |||||
Evaluation of goodwill for impairment | |||||
Description of the Matter | At November 30, 2025, the Company’s goodwill was $3.7 billion for its single reporting unit. As discussed in Note 2 to the consolidated financial statements, goodwill is tested annually for impairment at the reporting unit level on the first day of the fiscal fourth quarter or more frequently if events or changes in circumstances indicate that it may be impaired. The goodwill impairment test involves estimating the fair value of the reporting unit using a discounted cash flow model and the guideline public company approach. As discussed in Note 5 to the consolidated financial statements, subsequent to the annual goodwill impairment assessment, the Company experienced a sustained decrease in the market price of its common stock which necessitated an interim goodwill impairment test as of November 1, 2025. As a result of the interim quantitative goodwill impairment assessment, the fair value of the Company’s reporting unit was less than its carrying value and the Company recorded a goodwill impairment charge of $1.5 billion. Auditing the Company’s interim goodwill impairment charge was complex and required significant auditor judgment due to the high degree of estimation uncertainty involved in forecasting future revenue growth rates, adjusted earnings before income taxes, depreciation and amortization (EBITDA) margin projections, and calculating the weighted average cost of capital. These significant assumptions are forward looking and could be affected by future economic and market conditions and the performance of the Company’s reporting unit. | ||||
| How We Addressed the Matter in Our Audit | We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company’s interim goodwill impairment charge. Our procedures included, among others, testing controls over management’s review of the valuation models and significant assumptions described above. To test the estimated fair value of the Company’s reporting unit used in the interim goodwill impairment charge, we performed audit procedures that included, among others, assessing the methodologies used to determine the fair value of the Company’s reporting unit, testing the significant assumptions discussed above and testing the underlying data used by the Company in its analysis. We evaluated the Company’s assumptions around future revenue growth rates and adjusted EBITDA margin projections by comparing those assumptions to recent historical performance, financial forecasts, and current and forecasted economic and industry trends. We evaluated management’s historical accuracy of forecasting revenue and adjusted EBITDA margins by comparing past forecasts to subsequent actual activity. We also performed sensitivity analyses of significant assumptions to evaluate the changes in the fair value of the Company’s reporting unit that would result from changes in the assumptions. In addition, we involved our valuation specialists to assist in our evaluation of the methodologies and certain significant assumptions used by the Company, specifically the weighted average cost of capital. | ||||
| November 30, 2025 | November 30, 2024 | ||||||||||
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | 327,347 | $ | 240,571 | |||||||
| Accounts receivable, net | 1,999,021 | 1,926,737 | |||||||||
| Other current assets | 758,135 | 675,116 | |||||||||
| Total current assets | 3,084,503 | 2,842,424 | |||||||||
| Property and equipment, net | 735,550 | 714,517 | |||||||||
| Goodwill | 3,671,746 | 4,986,967 | |||||||||
| Intangible assets, net | 1,960,338 | 2,286,940 | |||||||||
| Deferred tax assets | 317,453 | 218,396 | |||||||||
| Other assets | 991,496 | 942,194 | |||||||||
| Total assets | $ | 10,761,086 | $ | 11,991,438 | |||||||
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ | 244,771 | $ | 209,812 | |||||||
| Current portion of long-term debt | 65,625 | 2,522 | |||||||||
| Accrued compensation and benefits | 764,962 | 706,619 | |||||||||
| Other accrued liabilities | 997,198 | 977,314 | |||||||||
| Income taxes payable | 123,794 | 99,546 | |||||||||
| Total current liabilities | 2,196,350 | 1,995,813 | |||||||||
| Long-term debt, net | 4,572,889 | 4,733,056 | |||||||||
| Other long-term liabilities | 950,983 | 910,271 | |||||||||
| Deferred tax liabilities | 296,519 | 312,574 | |||||||||
| Total liabilities | 8,016,741 | 7,951,714 | |||||||||
| Commitments and contingencies (Note 13) | |||||||||||
| Stockholders’ equity: | |||||||||||
Preferred stock, $0.0001 par value, 10,000 shares authorized and no shares issued and outstanding as of November 30, 2025 and 2024, respectively | — | — | |||||||||
Common stock, $0.0001 par value, 250,000 shares authorized; 70,316 and 68,849 shares issued as of November 30, 2025 and 2024, respectively, and 61,739 and 64,238 shares outstanding as of November 30, 2025 and 2024, respectively | 7 | 7 | |||||||||
| Additional paid-in capital | 3,783,972 | 3,683,608 | |||||||||
Treasury stock, 8,577 and 4,611 shares as of November 30, 2025 and 2024, respectively | (610,162) | (421,449) | |||||||||
| Retained earnings (deficit) | (177,010) | 1,191,871 | |||||||||
| Accumulated other comprehensive loss | (252,462) | (414,313) | |||||||||
| Total stockholders’ equity | 2,744,345 | 4,039,724 | |||||||||
| Total liabilities and stockholders’ equity | $ | 10,761,086 | $ | 11,991,438 | |||||||
| Fiscal Years Ended November 30, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Revenue | $ | 9,825,771 | $ | 9,618,900 | $ | 7,114,706 | |||||||||||
| Cost of revenue | 6,390,760 | 6,170,013 | 4,536,771 | ||||||||||||||
| Gross profit | 3,435,011 | 3,448,887 | 2,577,935 | ||||||||||||||
| Selling, general and administrative expenses | 2,825,468 | 2,852,500 | 1,916,608 | ||||||||||||||
| Impairment charges | 1,527,726 | — | — | ||||||||||||||
| Operating income (loss) | (918,183) | 596,387 | 661,327 | ||||||||||||||
| Interest expense and finance charges, net | 290,349 | 321,828 | 201,004 | ||||||||||||||
Other expense (income), net | (26,310) | (24,715) | 52,095 | ||||||||||||||
| Income (loss) before income taxes | (1,182,222) | 299,274 | 408,228 | ||||||||||||||
| Provision for income taxes | 96,702 | 48,057 | 94,386 | ||||||||||||||
| Net income (loss) | $ | (1,278,924) | $ | 251,217 | $ | 313,842 | |||||||||||
| Earnings (loss) per common share: | |||||||||||||||||
| Basic | $ | (20.36) | $ | 3.72 | $ | 5.72 | |||||||||||
| Diluted | $ | (20.36) | $ | 3.71 | $ | 5.70 | |||||||||||
| Weighted-average common shares outstanding: | |||||||||||||||||
| Basic | 63,012 | 64,977 | 53,801 | ||||||||||||||
| Diluted | 63,012 | 65,074 | 54,010 | ||||||||||||||
| Fiscal Years Ended November 30, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Net income (loss) | $ | (1,278,924) | $ | 251,217 | $ | 313,842 | |||||||||||
| Other comprehensive income (loss): | |||||||||||||||||
Unrealized gains (losses) of defined benefit plans, net of taxes of $(1,003), $(2,078), and $(894) for fiscal years ended November 30, 2025, 2024 and 2023, respectively | 3,702 | 5,988 | (2,800) | ||||||||||||||
Unrealized gains (losses) on hedges during the period, net of taxes of $2,051, $9,514, and $(4,938) for fiscal years ended November 30, 2025, 2024 and 2023, respectively | (3,578) | (34,029) | 10,610 | ||||||||||||||
Reclassification of net losses on hedges to net income (loss), net of taxes of $(2,322), $(1,230), and $(4,594) for fiscal years ended November 30, 2025, 2024 and 2023, respectively | 6,818 | 3,659 | 13,793 | ||||||||||||||
| Total change in unrealized gains (losses) on hedges, net of taxes | 3,240 | (30,370) | 24,403 | ||||||||||||||
Foreign currency translation adjustments for fiscal years ended November 30, 2025, 2024 and 2023 | 154,909 | (198,204) | 102,419 | ||||||||||||||
| Other comprehensive income (loss) | 161,851 | (222,586) | 124,022 | ||||||||||||||
| Comprehensive income (loss) | $ | (1,117,073) | $ | 28,631 | $ | 437,864 | |||||||||||
| Concentrix Corporation Stockholders’ Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Common Stock | Treasury stock | |||||||||||||||||||||||||||||||||||||||||||||||||
| Shares | Amount | Additional paid-in capital | Shares | Amount | Retained earnings (deficit) | Accumulated other comprehensive income (loss) | Total | |||||||||||||||||||||||||||||||||||||||||||
| Balances, November 30, 2022 | 52,367 | $ | 5 | $ | 2,428,313 | 1,271 | $ | (190,779) | $ | 774,114 | $ | (315,749) | $ | 2,695,904 | ||||||||||||||||||||||||||||||||||||
| Other comprehensive income | — | — | — | — | — | — | 124,022 | 124,022 | ||||||||||||||||||||||||||||||||||||||||||
| Common stock issued as acquisition purchase consideration | 14,862 | 2 | 1,084,894 | — | — | — | — | 1,084,896 | ||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation activity | 654 | — | 69,314 | — | — | — | — | 69,314 | ||||||||||||||||||||||||||||||||||||||||||
| Repurchase of common stock for tax withholdings on equity awards | — | — | — | 169 | (17,231) | — | — | (17,231) | ||||||||||||||||||||||||||||||||||||||||||
| Repurchase of common stock | — | — | — | 709 | (63,958) | — | — | (63,958) | ||||||||||||||||||||||||||||||||||||||||||
| Dividends | — | — | — | — | — | (63,495) | — | (63,495) | ||||||||||||||||||||||||||||||||||||||||||
| Net income | — | — | — | — | — | 313,842 | — | 313,842 | ||||||||||||||||||||||||||||||||||||||||||
| Balances, November 30, 2023 | 67,883 | 7 | 3,582,521 | 2,149 | (271,968) | 1,024,461 | (191,727) | 4,143,294 | ||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive loss | — | — | — | — | — | — | (222,586) | (222,586) | ||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation activity | 966 | — | 101,087 | — | — | — | — | 101,087 | ||||||||||||||||||||||||||||||||||||||||||
| Repurchase of common stock for tax withholdings on equity awards | — | — | — | 261 | (13,385) | — | — | (13,385) | ||||||||||||||||||||||||||||||||||||||||||
| Repurchase of common stock | — | — | — | 2,201 | (136,096) | — | — | (136,096) | ||||||||||||||||||||||||||||||||||||||||||
| Dividends | — | — | — | — | — | (83,807) | — | (83,807) | ||||||||||||||||||||||||||||||||||||||||||
| Net income | — | — | — | — | — | 251,217 | — | 251,217 | ||||||||||||||||||||||||||||||||||||||||||
| Balances, November 30, 2024 | 68,849 | 7 | 3,683,608 | 4,611 | (421,449) | 1,191,871 | (414,313) | 4,039,724 | ||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income | — | — | — | — | — | — | 161,851 | 161,851 | ||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation activity | 1,467 | — | 100,364 | — | — | — | — | 100,364 | ||||||||||||||||||||||||||||||||||||||||||
| Repurchase of common stock for tax withholdings on equity awards | — | — | — | 409 | (20,005) | — | — | (20,005) | ||||||||||||||||||||||||||||||||||||||||||
| Repurchase of common stock | — | — | — | 3,557 | (168,708) | — | — | (168,708) | ||||||||||||||||||||||||||||||||||||||||||
| Dividends | — | — | — | — | — | (89,957) | — | (89,957) | ||||||||||||||||||||||||||||||||||||||||||
| Net loss | — | — | — | — | — | (1,278,924) | — | (1,278,924) | ||||||||||||||||||||||||||||||||||||||||||
| Balances, November 30, 2025 | 70,316 | $ | 7 | $ | 3,783,972 | 8,577 | $ | (610,162) | $ | (177,010) | $ | (252,462) | $ | 2,744,345 | ||||||||||||||||||||||||||||||||||||
| Fiscal Years Ended November 30, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Cash flows from operating activities: | |||||||||||||||||
| Net income (loss) | $ | (1,278,924) | $ | 251,217 | $ | 313,842 | |||||||||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||||||||||||||
| Impairment charges | 1,527,726 | — | — | ||||||||||||||
| Depreciation | 226,101 | 246,920 | 173,463 | ||||||||||||||
| Amortization | 434,332 | 458,925 | 214,832 | ||||||||||||||
| Non-cash share-based compensation | 96,386 | 96,057 | 62,113 | ||||||||||||||
| Provision for credit losses | 5,738 | 7,057 | 10,236 | ||||||||||||||
| Deferred income taxes | (154,877) | (235,248) | (121,711) | ||||||||||||||
| Loss on call options | — | — | 14,629 | ||||||||||||||
| Amortization of debt discount and issuance costs | 23,548 | 25,276 | 6,089 | ||||||||||||||
| Pension and other post-retirement benefit costs | 16,565 | 16,097 | 11,328 | ||||||||||||||
| Pension and other post-retirement plan contributions | (4,058) | (4,442) | (12,143) | ||||||||||||||
| Change in acquisition contingent consideration | (1,958) | (29,268) | 15,681 | ||||||||||||||
| Other | 2,152 | 1,791 | 306 | ||||||||||||||
| Changes in operating assets and liabilities: | |||||||||||||||||
| Accounts receivable, net | (23,078) | (63,851) | (45,895) | ||||||||||||||
| Accounts payable | 28,474 | (25,819) | 9,341 | ||||||||||||||
| Other operating assets and liabilities | (91,160) | (77,220) | 25,897 | ||||||||||||||
| Net cash provided by operating activities | 806,967 | 667,492 | 678,008 | ||||||||||||||
| Cash flows from investing activities: | |||||||||||||||||
| Purchases of property and equipment | (234,496) | (238,762) | (180,532) | ||||||||||||||
| Premiums paid for call options | — | — | (14,629) | ||||||||||||||
| Acquisitions of business, net of cash and restricted cash acquired | (15,887) | (5,504) | (1,914,079) | ||||||||||||||
| Net cash used in investing activities | (250,383) | (244,266) | (2,109,240) | ||||||||||||||
| Cash flows from financing activities: | |||||||||||||||||
| Proceeds from the Restated Credit Facility - Term Loan | 1,500,000 | — | 294,702 | ||||||||||||||
| Repayments of the Restated Credit Facility - Term Loan | (1,034,375) | (450,000) | (194,702) | ||||||||||||||
| Repayments of the Prior Credit Facility - Term Loan | — | — | (25,000) | ||||||||||||||
| Proceeds from the Credit Facility - Revolver | 238,500 | — | — | ||||||||||||||
| Repayments of the Credit Facility - Revolver | (238,500) | — | — | ||||||||||||||
| Proceeds from the Securitization Facility | 2,347,700 | 2,191,000 | 1,964,000 | ||||||||||||||
| Repayments of the Securitization Facility | (2,181,700) | (1,948,500) | (2,192,000) | ||||||||||||||
| Proceeds from the issuance of Senior Notes | — | — | 2,136,987 | ||||||||||||||
| Other debt proceeds | — | 6,369 | — | ||||||||||||||
| Other debt repayments | (828,315) | (7,558) | — | ||||||||||||||
| Cash paid for debt issuance costs | (4,755) | (600) | (30,519) | ||||||||||||||
| Acquisition deferred consideration payment | (6,454) | — | — | ||||||||||||||
| Cash paid for acquired earnout liabilities | — | (22,737) | (13,309) | ||||||||||||||
| Proceeds from exercise of stock options | 3,978 | 5,030 | 7,201 | ||||||||||||||
| Repurchase of common stock for tax withholdings on equity awards | (20,005) | (13,385) | (17,231) | ||||||||||||||
| Repurchase of common stock | (168,708) | (136,096) | (63,958) | ||||||||||||||
| Dividends paid | (89,618) | (83,807) | (63,495) | ||||||||||||||
| Change in funds held for clients | (9,191) | (32,248) | — | ||||||||||||||
| Net cash provided by (used in) financing activities | (491,443) | (492,532) | 1,802,676 | ||||||||||||||
| Effect of exchange rate changes on cash, cash equivalents, cash held for sale and restricted cash | 26,382 | (17,577) | (12,420) | ||||||||||||||
| Net increase (decrease) in cash, cash equivalents, cash held for sale and restricted cash | 91,523 | (86,883) | 359,024 | ||||||||||||||
| Cash, cash equivalents, cash held for sale and restricted cash at beginning of year | 429,604 | 516,487 | 157,463 | ||||||||||||||
| Cash, cash equivalents, cash held for sale and restricted cash at end of year | $ | 521,127 | $ | 429,604 | $ | 516,487 | |||||||||||
| Fiscal Years Ended November 30, | |||||||||||||||||
2025 | 2024 | 2023 | |||||||||||||||
| Supplemental disclosures of cash flow information: | |||||||||||||||||
| Interest paid on borrowings | $ | 299,615 | $ | 282,270 | $ | 142,598 | |||||||||||
| Income taxes paid | $ | 270,328 | $ | 298,445 | $ | 217,252 | |||||||||||
| Supplemental disclosure of non-cash investing activities: | |||||||||||||||||
| Accrued costs for property and equipment purchases | $ | 28,781 | $ | 24,856 | $ | 26,374 | |||||||||||
| Equipment and furniture | 3 - 10 years | ||||
| Software | 3 - 7 years | ||||
| Leasehold improvements | 2 - 15 years | ||||
| Buildings and building improvements | 10 - 39 years | ||||
| Customer relationships | 10 - 15 years | ||||
| Technology | 5 years | ||||
| Trade names | 3 - 5 years | ||||
| Non-compete agreements | 3 years | ||||
| Options Outstanding | |||||||||||
Number of shares (in thousands) | Weighted- average exercise price per share | ||||||||||
| Balance as of November 30, 2022 | 395 | $ | 52.60 | ||||||||
| Options granted | — | — | |||||||||
| Options exercised | (100) | 45.50 | |||||||||
Options cancelled | (1) | 30.70 | |||||||||
| Balance as of November 30, 2023 | 294 | 54.45 | |||||||||
| Options granted | — | — | |||||||||
| Options exercised | (56) | 42.60 | |||||||||
| Balance as of November 30, 2024 | 238 | 57.21 | |||||||||
| Options granted | — | — | |||||||||
| Options exercised | (18) | 44.58 | |||||||||
Options cancelled | (2) | 55.12 | |||||||||
| Balance as of November 30, 2025 | 218 | $ | 58.28 | ||||||||
Number of shares (in thousands) | Weighted-average, grant-date fair value per share | ||||||||||
| Non-vested as of November 30, 2022 | 1,395 | $ | 124.69 | ||||||||
| Awards granted | 60 | 135.01 | |||||||||
Units granted (1) | 1,828 | 74.64 | |||||||||
Performance-based units vested in excess of target (2) | 17 | 159.97 | |||||||||
| Awards and units vested | (513) | 122.76 | |||||||||
| Awards and units cancelled/forfeited | (114) | 138.88 | |||||||||
| Non-vested as of November 30, 2023 | 2,673 | 92.80 | |||||||||
Units granted (1) | 2,824 | 52.94 | |||||||||
| Awards and units vested | (849) | 92.02 | |||||||||
| Awards and units cancelled/forfeited | (337) | 84.94 | |||||||||
| Non-vested as of November 30, 2024 | 4,311 | 68.35 | |||||||||
Units granted (1) | 1,817 | 47.81 | |||||||||
| Awards and units vested | (1,374) | 72.75 | |||||||||
| Awards and units cancelled/forfeited | (474) | 68.82 | |||||||||
| Non-vested as of November 30, 2025 | 4,280 | $ | 58.18 | ||||||||
Number of shares (in thousands) | Weighted-average, grant-date fair value per share | ||||||||||
Non-vested as of November 30, 2024 | — | $ | — | ||||||||
Units granted | 326 | 41.28 | |||||||||
Units cancelled/forfeited | (21) | 41.28 | |||||||||
Non-vested as of November 30, 2025 | 305 | $ | 41.28 | ||||||||
Number of shares (in thousands) | Weighted-average, grant-date fair value per share | ||||||||||
| Non-vested as of November 30, 2024 | — | $ | — | ||||||||
| Units granted | 622 | 46.93 | |||||||||
| Units cancelled/forfeited | (2) | 46.93 | |||||||||
Non-vested as of November 30, 2025 | 620 | $ | 46.93 | ||||||||
| As of November 30, | |||||||||||
| 2025 | 2024 | ||||||||||
| Cash and cash equivalents | $ | 327,347 | $ | 240,571 | |||||||
Cash held for sale | 2,057 | — | |||||||||
| Restricted cash included in other current assets | 191,723 | 189,033 | |||||||||
Cash, cash equivalents, cash held for sale and restricted cash | $ | 521,127 | $ | 429,604 | |||||||
| As of November 30, | |||||||||||
| 2025 | 2024 | ||||||||||
| Billed accounts receivable | $ | 1,102,601 | $ | 1,080,778 | |||||||
| Unbilled accounts receivable | 913,863 | 860,266 | |||||||||
Less: Allowance for credit losses | (17,443) | (14,307) | |||||||||
| Accounts receivable, net | $ | 1,999,021 | $ | 1,926,737 | |||||||
| Fiscal Years Ended November 30, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Balance at beginning of period | $ | 14,307 | $ | 12,533 | $ | 4,797 | |||||||||||
Net additions | 5,738 | 7,057 | 10,236 | ||||||||||||||
Write-offs | (2,602) | (5,283) | (2,500) | ||||||||||||||
| Balance at end of period | $ | 17,443 | $ | 14,307 | $ | 12,533 | |||||||||||
| As of November 30, | |||||||||||
| 2025 | 2024 | ||||||||||
| Land | $ | 28,391 | $ | 28,235 | |||||||
Equipment, computers, and software | 969,841 | 853,558 | |||||||||
| Furniture and fixtures | 172,154 | 151,477 | |||||||||
Buildings, building improvements, and leasehold improvements | 704,074 | 617,880 | |||||||||
| Construction-in-progress | 39,098 | 44,566 | |||||||||
| Total property and equipment, gross | $ | 1,913,558 | $ | 1,695,716 | |||||||
| Less: Accumulated depreciation | (1,178,008) | (981,199) | |||||||||
| Property and equipment, net | $ | 735,550 | $ | 714,517 | |||||||
| As of November 30, | |||||||||||
| 2025 | 2024 | ||||||||||
| Property and equipment, net: | |||||||||||
| Philippines | $ | 105,475 | $ | 82,864 | |||||||
United States | 93,773 | 118,732 | |||||||||
India | 57,585 | 49,339 | |||||||||
France | 56,386 | 59,645 | |||||||||
| Others | 422,331 | 403,937 | |||||||||
| Total | $ | 735,550 | $ | 714,517 | |||||||
Unrecognized gains (losses) on defined benefit plan, net of taxes | Unrealized gains (losses) on hedges, net of taxes | Foreign currency translation adjustment and other, net of taxes | Total | ||||||||||||||||||||
| Balances at November 30, 2023 | $ | (11,271) | $ | 4,489 | $ | (184,945) | $ | (191,727) | |||||||||||||||
| Other comprehensive income (loss) before reclassification | 5,988 | (34,029) | (198,204) | (226,245) | |||||||||||||||||||
Reclassification of losses from other comprehensive income (loss) | — | 3,659 | — | 3,659 | |||||||||||||||||||
| Balances at November 30, 2024 | $ | (5,283) | $ | (25,881) | $ | (383,149) | $ | (414,313) | |||||||||||||||
| Other comprehensive income (loss) before reclassification | 3,702 | (3,578) | 154,909 | 155,033 | |||||||||||||||||||
Reclassification of losses from other comprehensive income (loss) | — | 6,818 | — | 6,818 | |||||||||||||||||||
| Balances at November 30, 2025 | $ | (1,581) | $ | (22,641) | $ | (228,240) | $ | (252,462) | |||||||||||||||
| Fiscal Years Ended November 30, | |||||||||||
| 2025 | 2024 | ||||||||||
| Balance at beginning of year | $ | 4,986,967 | $ | 5,078,668 | |||||||
| Acquisitions | 17,370 | 2,000 | |||||||||
| Acquisition measurement period adjustments | — | 60,630 | |||||||||
| Assets held for sale | (2,570) | — | |||||||||
| Impairment charge | (1,523,266) | — | |||||||||
| Foreign currency translation | 193,245 | (154,331) | |||||||||
| Balance at end of year | $ | 3,671,746 | $ | 4,986,967 | |||||||
| As of November 30, 2025 | As of November 30, 2024 | ||||||||||||||||||||||||||||||||||
Gross amounts | Accumulated amortization | Net amounts | Gross amounts | Accumulated amortization | Net amounts | ||||||||||||||||||||||||||||||
| Customer relationships | $ | 3,736,591 | $ | (1,822,119) | $ | 1,914,472 | $ | 3,594,694 | $ | (1,399,588) | $ | 2,195,106 | |||||||||||||||||||||||
| Technology | 79,603 | (64,089) | 15,514 | 79,645 | (50,119) | 29,526 | |||||||||||||||||||||||||||||
| Trade names | 123,484 | (93,132) | 30,352 | 113,758 | (51,503) | 62,255 | |||||||||||||||||||||||||||||
| Non-compete agreements | 2,200 | (2,200) | — | 2,200 | (2,147) | 53 | |||||||||||||||||||||||||||||
| $ | 3,941,878 | $ | (1,981,540) | $ | 1,960,338 | $ | 3,790,297 | $ | (1,503,357) | $ | 2,286,940 | ||||||||||||||||||||||||
| Fiscal Years Ending November 30, | Amortization Expense | ||||
| 2026 | $ | 393,559 | |||
| 2027 | 297,133 | ||||
| 2028 | 251,871 | ||||
| 2029 | 209,650 | ||||
| 2030 | 177,687 | ||||
| Thereafter | 630,438 | ||||
| Total | $ | 1,960,338 | |||
| Value as of | ||||||||||||||
| Balance Sheet Line Item | November 30, 2025 | November 30, 2024 | ||||||||||||
| Derivative instruments not designated as hedging instruments: | ||||||||||||||
| Foreign exchange forward contracts (notional value) | $ | — | $ | 458,482 | ||||||||||
Other current assets | — | 13,935 | ||||||||||||
Other accrued liabilities | — | 167 | ||||||||||||
Derivative instruments designated as fair value hedges: | ||||||||||||||
Cross-currency interest rate swaps (notional value) | $ | 1,112,706 | $ | 471,604 | ||||||||||
| Other assets | 5,343 | — | ||||||||||||
Other current liabilities and other long-term liabilities | 49,319 | 7,468 | ||||||||||||
| Derivative instruments designated as cash flow hedges: | ||||||||||||||
Interest rate swaps (notional value) | $ | 750,000 | $ | — | ||||||||||
Other long-term liabilities | 3,357 | — | ||||||||||||
| Foreign exchange forward contracts (notional value) | $ | 1,049,896 | $ | 1,049,787 | ||||||||||
Other current assets and other assets | 914 | 578 | ||||||||||||
Other accrued liabilities and other long-term liabilities | 21,424 | 22,155 | ||||||||||||
| Fiscal Years Ended November 30, | |||||||||||||||||||||||
Locations of gain (loss) in statement of operations | 2025 | 2024 | 2023 | ||||||||||||||||||||
Derivative instruments designated as cash flow and fair value hedges: | |||||||||||||||||||||||
Gains (losses) recognized in OCI: | |||||||||||||||||||||||
Foreign exchange forward contracts | $ | (8,072) | $ | (38,459) | $ | 19,199 | |||||||||||||||||
Cross-currency interest rate swaps | 5,800 | (5,084) | (3,651) | ||||||||||||||||||||
Interest rate swaps | (3,357) | — | — | ||||||||||||||||||||
| Total | $ | (5,629) | $ | (43,543) | $ | 15,548 | |||||||||||||||||
Gains (losses) reclassified from AOCL into income: | |||||||||||||||||||||||
Foreign exchange forward contracts | |||||||||||||||||||||||
Gain (loss) reclassified from AOCL into income | Revenue for services | $ | — | $ | — | $ | 222 | ||||||||||||||||
Gain (loss) reclassified from AOCL into income | Cost of revenue | (6,484) | (4,028) | (13,864) | |||||||||||||||||||
Gain (loss) reclassified from AOCL into income | Selling, general and administrative expenses | (2,656) | (861) | (4,745) | |||||||||||||||||||
| Total | $ | (9,140) | $ | (4,889) | $ | (18,387) | |||||||||||||||||
| Derivative instruments not designated as hedging instruments: | |||||||||||||||||||||||
Gain (loss) recognized from foreign exchange forward contracts, net(1) | Other expense (income), net | $ | 6,429 | $ | 9,940 | $ | (13,007) | ||||||||||||||||
Gain (loss) recognized from foreign exchange call options contracts, net | Other expense (income), net | — | — | (14,629) | |||||||||||||||||||
Total | $ | 6,429 | $ | 9,940 | $ | (27,636) | |||||||||||||||||
| As of November 30, 2025 | As of November 30, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||
| Fair value measurement category | Fair value measurement category | ||||||||||||||||||||||||||||||||||||||||||||||
| Total | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||||||||||||||||||||||
Assets measured at fair value: | |||||||||||||||||||||||||||||||||||||||||||||||
Cash and cash equivalents, including cash held for sale | $ | 329,404 | $ | 329,404 | $ | — | $ | — | $ | 240,571 | $ | 240,571 | $ | — | $ | — | |||||||||||||||||||||||||||||||
Restricted cash | 191,723 | 191,723 | — | — | 189,033 | 189,033 | — | — | |||||||||||||||||||||||||||||||||||||||
| Forward foreign currency exchange contracts | 914 | — | 914 | — | 14,513 | — | 14,513 | — | |||||||||||||||||||||||||||||||||||||||
| Cross-currency interest rate swaps | 5,343 | — | 5,343 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||
Liabilities measured at fair value: | |||||||||||||||||||||||||||||||||||||||||||||||
| Forward foreign currency exchange contracts | 21,424 | — | 21,424 | — | 22,322 | — | 22,322 | — | |||||||||||||||||||||||||||||||||||||||
Cross-currency interest rate swaps | 49,319 | — | 49,319 | — | 7,468 | — | 7,468 | — | |||||||||||||||||||||||||||||||||||||||
Interest rate swaps | 3,357 | — | 3,357 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||
Acquisition contingent consideration | 7,866 | — | — | 7,866 | 13,373 | — | — | 13,373 | |||||||||||||||||||||||||||||||||||||||
Liabilities measured at other than fair value: | |||||||||||||||||||||||||||||||||||||||||||||||
Long term debt (senior notes) | |||||||||||||||||||||||||||||||||||||||||||||||
Fair value | 2,184,727 | — | 2,184,727 | — | 2,202,221 | — | 2,202,221 | — | |||||||||||||||||||||||||||||||||||||||
Carrying amount | 2,139,537 | — | — | — | 2,135,576 | — | — | — | |||||||||||||||||||||||||||||||||||||||
| As of November 30, | |||||||||||
| 2025 | 2024 | ||||||||||
| Credit Facility - current portion of term loans component | $ | 65,625 | $ | — | |||||||
| Other loans | — | 2,522 | |||||||||
| Current portion of long-term debt | $ | 65,625 | $ | 2,522 | |||||||
6.650% Senior Notes due 2026 | $ | 800,000 | $ | 800,000 | |||||||
6.600% Senior Notes due 2028 | 800,000 | 800,000 | |||||||||
6.850% Senior Notes due 2033 | 550,000 | 550,000 | |||||||||
| Credit Facility - term loans component | 1,900,000 | 1,500,000 | |||||||||
| Securitization Facility | 537,000 | 371,000 | |||||||||
| Sellers’ Note | — | 740,466 | |||||||||
| Other loans | — | 3,643 | |||||||||
| Long-term debt, before unamortized debt discount and issuance costs | 4,587,000 | 4,765,109 | |||||||||
| Less: unamortized debt discount and issuance costs | (14,111) | (32,053) | |||||||||
| Long-term debt, net | $ | 4,572,889 | $ | 4,733,056 | |||||||
| Amount | |||||
| Fiscal Years Ending November 30, | |||||
2026 (1) | $ | 865,625 | |||
| 2027 | 1,087,000 | ||||
| 2028 | 1,718,750 | ||||
| 2029 | 25,000 | ||||
| 2030 | 406,250 | ||||
| Thereafter | 550,000 | ||||
| Total | $ | 4,652,625 | |||
| Fiscal Years Ended November 30, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Industry vertical: | |||||||||||||||||
| Technology and consumer electronics | $ | 2,666,072 | $ | 2,674,040 | $ | 2,205,834 | |||||||||||
Retail, travel and e-commerce | 2,433,885 | 2,361,866 | 1,448,666 | ||||||||||||||
| Communications and media | 1,592,373 | 1,527,922 | 1,117,694 | ||||||||||||||
| Banking, financial services and insurance | 1,536,223 | 1,455,641 | 1,091,853 | ||||||||||||||
| Healthcare | 725,283 | 727,389 | 696,266 | ||||||||||||||
| Other | 871,935 | 872,042 | 554,393 | ||||||||||||||
| Total | $ | 9,825,771 | $ | 9,618,900 | $ | 7,114,706 | |||||||||||
| Fiscal Years Ended November 30, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Revenue by geography: | |||||||||||||||||
| Philippines | $ | 1,594,559 | $ | 1,596,578 | $ | 1,585,878 | |||||||||||
India | 1,126,061 | 1,054,460 | 898,250 | ||||||||||||||
United States | 1,051,700 | 1,110,763 | 1,304,797 | ||||||||||||||
| Great Britain | 356,490 | 394,945 | 205,437 | ||||||||||||||
| Germany | 334,293 | 388,005 | 232,729 | ||||||||||||||
| Canada | 302,085 | 307,590 | 317,410 | ||||||||||||||
| Others | 5,060,583 | 4,766,559 | 2,570,205 | ||||||||||||||
| Total | $ | 9,825,771 | $ | 9,618,900 | $ | 7,114,706 | |||||||||||
| Fiscal Years Ended November 30, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Service costs | $ | 12,289 | $ | 9,033 | $ | 6,937 | |||||||||||
| Interest costs on projected benefit obligation | 10,379 | 10,893 | 10,306 | ||||||||||||||
| Expected return on plan assets | (6,918) | (5,295) | (6,208) | ||||||||||||||
| Amortization and deferrals, net | 1,696 | 1,457 | 98 | ||||||||||||||
| Settlement charges | — | 9 | 195 | ||||||||||||||
Curtailment gain | (881) | — | — | ||||||||||||||
| Total pension costs | $ | 16,565 | $ | 16,097 | $ | 11,328 | |||||||||||
| Fiscal Years Ended November 30, | |||||||||||
| 2025 | 2024 | ||||||||||
| Change in Benefit Obligation: | |||||||||||
| Benefit obligation at beginning of year | $ | 213,865 | $ | 208,565 | |||||||
Service costs | 12,289 | 9,033 | |||||||||
Interest costs | 10,379 | 10,893 | |||||||||
Actuarial losses | 584 | 6,017 | |||||||||
Benefits paid | (20,094) | (17,161) | |||||||||
Settlements | — | (490) | |||||||||
Curtailments | (1,784) | — | |||||||||
Foreign currency adjustments | (1,284) | (2,992) | |||||||||
| Projected obligation at end of year | $ | 213,955 | $ | 213,865 | |||||||
| Change in Plan Assets: | |||||||||||
| Fair value of plan assets at beginning of year | $ | 135,923 | $ | 126,752 | |||||||
Actual return on assets | 8,395 | 17,251 | |||||||||
Settlements | — | (83) | |||||||||
Employer contributions | 4,058 | 4,442 | |||||||||
Benefits paid | (14,815) | (12,279) | |||||||||
Foreign currency adjustments | (670) | (160) | |||||||||
| Fair value of plan assets at end of year | $ | 132,891 | $ | 135,923 | |||||||
| Funded Status of Plans: | |||||||||||
| Unfunded status | $ | 81,064 | $ | 77,942 | |||||||
| As of November 30, | |||||||||||
| 2025 | 2024 | ||||||||||
| Current liability | $ | 16,623 | $ | 16,694 | |||||||
| Non-current liability | 64,441 | 61,248 | |||||||||
| Total | $ | 81,064 | $ | 77,942 | |||||||
| As of November 30, | |||||||||||
| 2025 | 2024 | ||||||||||
| Discount rate | 3.6% - 6.1% | 3.2% - 6.7% | |||||||||
| Interest crediting rate for cash balance plan | 4.0 | % | 4.0 | % | |||||||
| Expected rate of future compensation growth | 1.5% - 8.0% | 2.5% - 7.0% | |||||||||
| Fiscal Years Ended November 30, | |||||||||||
| 2025 | 2024 | ||||||||||
| Discount rate | 3.2% - 6.7% | 4.0% - 7.5% | |||||||||
| Interest crediting rate for cash balance plan | 4.0 | % | 4.0 | % | |||||||
| Expected return on plan assets | 1.0% - 7.0% | 3.6% - 7.1% | |||||||||
| Expected rate of future compensation growth | 2.5% - 7.5% | 1.8% - 8.0% | |||||||||
| Investments | As of November 30, 2025 | As of Quoted Prices in Active Markets for Identical Assets (Level 1) | As of Significant Other Observable Inputs (Level 2) | As of Significant Unobservable Inputs (Level 3) | ||||||||||||||||||||||
| Cash and cash equivalents | $ | 3,682 | $ | 3,682 | $ | — | $ | — | ||||||||||||||||||
| Common/collective trusts: | ||||||||||||||||||||||||||
| Fixed income | 86,623 | — | 86,623 | — | ||||||||||||||||||||||
| U.S. large cap | 13,642 | — | 13,642 | — | ||||||||||||||||||||||
| U.S. small cap | 3,489 | — | 3,489 | — | ||||||||||||||||||||||
| International equity | 13,825 | — | 13,825 | — | ||||||||||||||||||||||
| Governmental bonds | 6,873 | — | 6,873 | — | ||||||||||||||||||||||
| Corporate bonds | 4,757 | — | 4,757 | — | ||||||||||||||||||||||
| Total investments | $ | 132,891 | $ | 3,682 | $ | 129,209 | $ | — | ||||||||||||||||||
| Investments | As of November 30, 2024 | As of Quoted Prices in Active Markets for Identical Assets (Level 1) | As of Significant Other Observable Inputs (Level 2) | As of Significant Unobservable Inputs (Level 3) | ||||||||||||||||||||||
| Cash and cash equivalents | $ | 3,606 | $ | 3,606 | $ | — | $ | — | ||||||||||||||||||
| Common/collective trusts: | ||||||||||||||||||||||||||
| Fixed income | 59,928 | — | 59,928 | — | ||||||||||||||||||||||
| U.S. large cap | 25,924 | — | 25,924 | — | ||||||||||||||||||||||
| U.S. small cap | 7,662 | — | 7,662 | — | ||||||||||||||||||||||
| International equity | 27,168 | — | 27,168 | — | ||||||||||||||||||||||
| Governmental bonds | 8,501 | — | 8,501 | — | ||||||||||||||||||||||
| Corporate bonds | 3,134 | — | 3,134 | — | ||||||||||||||||||||||
| Total investments | $ | 135,923 | $ | 3,606 | $ | 132,317 | $ | — | ||||||||||||||||||
| Fiscal Years Ending November 30, | |||||
| 2026 | $ | 30,790 | |||
| 2027 | 27,236 | ||||
| 2028 | 25,420 | ||||
| 2029 | 23,419 | ||||
| 2030 | 22,260 | ||||
| Thereafter | 98,213 | ||||
| Total | $ | 227,338 | |||
| Fiscal Years Ended November 30, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Operating lease cost | $ | 323,427 | $ | 295,111 | $ | 216,774 | |||||||||||
| Short-term lease cost | 69,823 | 89,001 | 21,802 | ||||||||||||||
| Variable lease cost | 53,709 | 44,237 | 58,283 | ||||||||||||||
| Sublease income | (2,959) | (4,492) | (5,394) | ||||||||||||||
| Total operating lease cost | $ | 444,000 | $ | 423,857 | $ | 291,465 | |||||||||||
| Fiscal Years Ending November 30, | |||||
| 2026 | $ | 312,965 | |||
| 2027 | 251,660 | ||||
| 2028 | 192,770 | ||||
| 2029 | 129,777 | ||||
| 2030 | 71,067 | ||||
| Thereafter | 86,524 | ||||
| Total payments | 1,044,763 | ||||
| Less: imputed interest* | 146,580 | ||||
| Total present value of lease payments | $ | 898,183 | |||
| As of November 30, | ||||||||||||||||||||
Description | Balance Sheet location | 2025 | 2024 | |||||||||||||||||
| Operating lease ROU assets | $ | 857,025 | $ | 816,550 | ||||||||||||||||
| Current operating lease liabilities | 256,739 | 235,912 | ||||||||||||||||||
| Non-current operating lease liabilities | 641,444 | 625,888 | ||||||||||||||||||
| Fiscal Years Ended November 30, | ||||||||||||||||||||
| 2025 | 2024 | 2023 | ||||||||||||||||||
| Cash paid for amounts included in the measurement of lease liabilities | $ | 345,027 | $ | 310,859 | $ | 225,142 | ||||||||||||||
| Non-cash ROU assets obtained in exchange for lease liabilities | 264,095 | 295,894 | 152,071 | |||||||||||||||||
| As of November 30, | ||||||||||||||
| 2025 | 2024 | |||||||||||||
| Weighted-average remaining lease term (years) | 4.20 | 4.50 | ||||||||||||
| Weighted-average discount rate | 6.85 | % | 6.91 | % | ||||||||||
| Fiscal Years Ended November 30, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| United States | $ | (775,986) | $ | 4,279 | $ | (51,820) | |||||||||||
| Foreign | (406,236) | 294,995 | 460,048 | ||||||||||||||
Total income (loss) before income taxes | $ | (1,182,222) | $ | 299,274 | $ | 408,228 | |||||||||||
| Fiscal Years Ended November 30, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
Current tax provision: | |||||||||||||||||
| Federal | $ | 81,553 | $ | 89,987 | $ | 78,961 | |||||||||||
| State | 28,394 | 7,734 | 11,064 | ||||||||||||||
| Foreign | 141,632 | 185,584 | 126,072 | ||||||||||||||
| $ | 251,579 | $ | 283,305 | $ | 216,097 | ||||||||||||
Deferred tax benefit: | |||||||||||||||||
| Federal | $ | (77,575) | $ | (104,236) | $ | (97,371) | |||||||||||
| State | (9,809) | (20,462) | (12,850) | ||||||||||||||
| Foreign | (67,493) | (110,550) | (11,490) | ||||||||||||||
| (154,877) | (235,248) | (121,711) | |||||||||||||||
| Total income tax provision | $ | 96,702 | $ | 48,057 | $ | 94,386 | |||||||||||
| As of November 30, | |||||||||||
| 2025 | 2024 | ||||||||||
| Deferred tax assets | $ | 317,453 | $ | 218,396 | |||||||
| Deferred tax liabilities | 296,519 | 312,574 | |||||||||
Total net deferred tax asset (liability) | $ | 20,934 | $ | (94,178) | |||||||
| As of November 30, | |||||||||||
| 2025 | 2024 | ||||||||||
| Assets: | |||||||||||
Net operating losses | $ | 172,819 | $ | 172,182 | |||||||
Accruals and other reserves | 87,492 | 78,308 | |||||||||
Depreciation and amortization | 120,727 | 107,095 | |||||||||
U.S. interest limitation carry forward | 88,219 | 49,481 | |||||||||
Share-based compensation expense | 24,402 | 17,714 | |||||||||
Deferred revenue | 5,764 | 5,280 | |||||||||
Tax credits | 5,516 | 5,082 | |||||||||
Foreign tax credit | 9,610 | 5,199 | |||||||||
| Operating lease liabilities | 202,480 | 201,266 | |||||||||
| Intercompany loans payable | 119,678 | 110,708 | |||||||||
Other | 13,548 | 32,048 | |||||||||
Gross deferred tax assets | 850,255 | 784,363 | |||||||||
Valuation allowance | (147,609) | (125,163) | |||||||||
Total deferred tax assets | $ | 702,646 | $ | 659,200 | |||||||
| Liabilities: | |||||||||||
Intangible assets | $ | 447,819 | $ | 529,129 | |||||||
Unremitted non-US earnings | 48,952 | 42,433 | |||||||||
| Operating lease right-of-use assets | 184,941 | 181,816 | |||||||||
Total deferred tax liabilities | 681,712 | 753,378 | |||||||||
Net deferred tax asset (liability) | $ | 20,934 | $ | (94,178) | |||||||
| Fiscal Years Ended November 30, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Federal statutory income tax rate | 21.0 | % | 21.0 | % | 21.0 | % | |||||||||||
| State taxes, net of federal income tax benefit | (1.1) | % | (1.8) | % | (1.0) | % | |||||||||||
| International rate difference | (1.7) | % | (9.0) | % | (2.3) | % | |||||||||||
| Withholding taxes | (1.6) | % | 3.9 | % | 2.5 | % | |||||||||||
| Uncertain tax benefits | 0.4 | % | 0.7 | % | 1.3 | % | |||||||||||
| Changes in valuation allowance | (1.4) | % | 6.5 | % | 1.7 | % | |||||||||||
Impact of inclusion of foreign income (1) | (0.1) | % | 0.3 | % | (4.7) | % | |||||||||||
Impairment charges | (26.7) | % | — | % | — | % | |||||||||||
Capital loss | — | % | (12.4) | % | — | % | |||||||||||
Other (2) | 3.0 | % | 6.9 | % | 4.6 | % | |||||||||||
| Effective income tax rate | (8.2) | % | 16.1 | % | 23.1 | % | |||||||||||
| Balance as of November 30, 2022 | $ | 70,963 | |||
| Additions based on tax positions related to the current year | 5,819 | ||||
Additions based on tax positions related to the prior year / acquisition | 6,071 | ||||
| Lapse of statute of limitations | (4,938) | ||||
Changes due to translation of foreign currencies | 1,407 | ||||
| Balance as of November 30, 2023 | 79,322 | ||||
| Additions based on tax positions related to the current year | 11,081 | ||||
Additions based on tax positions related to the prior year / acquisition | 18,576 | ||||
| Lapse of statute of limitations | (8,071) | ||||
Changes due to translation of foreign currencies | (132) | ||||
Settlements | (428) | ||||
| Balance as of November 30, 2024 | 100,348 | ||||
| Additions based on tax positions related to the current year | 23,367 | ||||
Additions based on tax positions related to the prior year | 1,197 | ||||
| Lapse of statute of limitations | (42,095) | ||||
Changes due to translation of foreign currencies | (643) | ||||
| Balance as of November 30, 2025 | $ | 82,174 | |||
| Fiscal Years Ended November 30, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Basic earnings (loss) per common share: | |||||||||||||||||
| Net income (loss) | $ | (1,278,924) | $ | 251,217 | $ | 313,842 | |||||||||||
Less: net income allocated to participating securities(1) | (4,103) | (9,504) | (6,001) | ||||||||||||||
| Net income (loss) attributable to common stockholders | $ | (1,283,027) | $ | 241,713 | $ | 307,841 | |||||||||||
| Weighted-average number of common shares - basic | 63,012 | 64,977 | 53,801 | ||||||||||||||
| Basic earnings (loss) per common share | $ | (20.36) | $ | 3.72 | $ | 5.72 | |||||||||||
| Diluted earnings (loss) per common share: | |||||||||||||||||
| Net income (loss) | $ | (1,278,924) | $ | 251,217 | $ | 313,842 | |||||||||||
Less: net income allocated to participating securities(1) | (4,103) | (9,490) | (5,978) | ||||||||||||||
| Net income (loss) attributable to common stockholders | $ | (1,283,027) | $ | 241,727 | $ | 307,864 | |||||||||||
| Weighted-average number of common shares - basic | 63,012 | 64,977 | 53,801 | ||||||||||||||
| Effect of dilutive securities: | |||||||||||||||||
Stock options and certain restricted stock units(2) | — | 97 | 209 | ||||||||||||||
| Weighted-average number of common shares - diluted | 63,012 | 65,074 | 54,010 | ||||||||||||||
| Diluted earnings (loss) per common share | $ | (20.36) | $ | 3.71 | $ | 5.70 | |||||||||||
| Announcement Date | Record Date | Per Share Dividend Amount | Payment Date | ||||||||
| January 24, 2024 | February 5, 2024 | $0.3025 | February 15, 2024 | ||||||||
| March 26, 2024 | April 26, 2024 | $0.3025 | May 7, 2024 | ||||||||
| June 26, 2024 | July 26, 2024 | $0.3025 | August 6, 2024 | ||||||||
| September 25, 2024 | October 25, 2024 | $0.33275 | November 5, 2024 | ||||||||
| January 15, 2025 | January 31, 2025 | $0.33275 | February 11, 2025 | ||||||||
| March 26, 2025 | April 25, 2025 | $0.33275 | May 6, 2025 | ||||||||
| June 26, 2025 | July 25, 2025 | $0.33275 | August 5, 2025 | ||||||||
| September 25, 2025 | October 24, 2025 | $0.36 | November 4, 2025 | ||||||||
| Fiscal Years Ended November 30, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Revenue | $ | 9,825,771 | $ | 9,618,900 | $ | 7,114,706 | |||||||||||
Cost of revenue (1) | 6,359,357 | 6,150,666 | 4,535,003 | ||||||||||||||
Selling, general and administrative expenses (2) | 1,997,095 | 1,913,309 | 1,397,914 | ||||||||||||||
Acquisition-related, integration and restructuring expenses | 101,468 | 156,771 | 69,674 | ||||||||||||||
| Share-based compensation expense | 97,875 | 95,922 | 62,493 | ||||||||||||||
| Amortization of intangible assets | 434,332 | 458,925 | 214,832 | ||||||||||||||
| Impairment charges | 1,527,726 | — | — | ||||||||||||||
| Depreciation expense | 226,101 | 246,920 | 173,463 | ||||||||||||||
Operating income (loss) | (918,183) | 596,387 | 661,327 | ||||||||||||||
Interest expense and finance charges, net | 290,349 | 321,828 | 201,004 | ||||||||||||||
Other expense (income), net | (26,310) | (24,715) | 52,095 | ||||||||||||||
Provision for income taxes | 96,702 | 48,057 | 94,386 | ||||||||||||||
Net income (loss) | $ | (1,278,924) | $ | 251,217 | $ | 313,842 | |||||||||||
| Additions/Deductions | |||||||||||||||||||||||||||||
Balances at Beginning of Fiscal Year | Charged to Revenue and Expense, net | Additions from Acquisitions | Reclassifications and Write-offs | Balances at End of Fiscal Year | |||||||||||||||||||||||||
Fiscal Year Ended November 30, 2025 | |||||||||||||||||||||||||||||
| Allowance for deferred tax assets | $ | 125,163 | $ | 19,084 | $ | — | $ | 3,362 | $ | 147,609 | |||||||||||||||||||
Fiscal Year Ended November 30, 2024 | |||||||||||||||||||||||||||||
| Allowance for deferred tax assets | $ | 117,679 | $ | 40,340 | $ | — | $ | (32,856) | $ | 125,163 | |||||||||||||||||||
Fiscal Year Ended November 30, 2023 | |||||||||||||||||||||||||||||
| Allowance for deferred tax assets | $ | 103,169 | $ | 4,823 | $ | 11,760 | $ | (2,073) | $ | 117,679 | |||||||||||||||||||
| Exhibit No. | Exhibit Description | |||||||
| 2.1 | ||||||||
| 2.2 | ||||||||
| 3.1 | ||||||||
| 3.2 | ||||||||
| 4.1 | ||||||||
| 4.2 | ||||||||
| 4.3 | ||||||||
| 4.4 | ||||||||
| 4.5 | ||||||||
| 10.1 | ||||||||
| 10.2 | ||||||||
| 10.3 | ||||||||
| 10.4 | ||||||||
| 10.5 | ||||||||
| 10.6 | ||||||||
| 10.7 | ||||||||
| 10.8 | ||||||||
| 10.9 | ||||||||
| 10.10 | ||||||||
| 10.11 | ||||||||
| 10.12 | ||||||||
| 10.13 | ||||||||
| 10.14 | ||||||||
| 10.15 | ||||||||
10.16 | ||||||||
10.17 | ||||||||
10.18 | ||||||||
10.19 | ||||||||
10.20 | ||||||||
| 10.21 | ||||||||
| 10.22 | ||||||||
| 10.23 | ||||||||
| 10.24 | ||||||||
| 10.25 | ||||||||
| 10.26 | ||||||||
| 10.27 | ||||||||
| 10.28 | ||||||||
| 16.1 | ||||||||
| 19.1 | ||||||||
| 21.1 | ||||||||
| 23.1 | ||||||||
| 23.2 | ||||||||
| 24.1 | ||||||||
| 31.1 | ||||||||
| 31.2 | ||||||||
| 32.1 | ||||||||
| 97.1 | ||||||||
| 101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | |||||||
101.SCH | Inline XBRL Taxonomy Extension Schema Document. | |||||||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | |||||||
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. | |||||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | |||||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. | |||||||
| 104 | Cover Page Interactive Data File (Embedded within the Inline XBRL document and included in Exhibit 101). | |||||||
| CONCENTRIX CORPORATION | |||||
| By: | /s/ Christopher Caldwell | ||||
| Christopher Caldwell | |||||
| President and Chief Executive Officer | |||||
| Name | Title | Date | ||||||||||||
/s/ Christopher Caldwell | President and Chief Executive Officer (Principal Executive Officer) and Director | January 28, 2026 | ||||||||||||
| Christopher Caldwell | ||||||||||||||
/s/ Andre Valentine | Chief Financial Officer (Principal Financial and Principal Accounting Officer) | January 28, 2026 | ||||||||||||
| Andre Valentine | ||||||||||||||
/s/ Teh-Chien Chou | Director | January 28, 2026 | ||||||||||||
| Teh-Chien Chou | ||||||||||||||
/s/ LaVerne Council | Director | January 28, 2026 | ||||||||||||
| LaVerne Council | ||||||||||||||
/s/ Jennifer Deason | Director | January 28, 2026 | ||||||||||||
| Jennifer Deason | ||||||||||||||
/s/ Nicolas Gheysens | Director | January 28, 2026 | ||||||||||||
Nicolas Gheysens | ||||||||||||||
/s/ Kathryn Hayley | Director | January 28, 2026 | ||||||||||||
| Kathryn Hayley | ||||||||||||||
/s/ Kathryn Marinello | Director | January 28, 2026 | ||||||||||||
| Kathryn Marinello | ||||||||||||||
/s/ Dennis Polk | Director | January 28, 2026 | ||||||||||||
| Dennis Polk | ||||||||||||||
/s/ Ann Vezina | Director | January 28, 2026 | ||||||||||||
| Ann Vezina | ||||||||||||||
[NAME OF RECIPIENT] | CONCENTRIX CORPORATION By: Its: | ||||
2020 EMPLOYEE STOCK PURCHASE PLAN | 1 | ||||
SECTION 1 Purpose of the Plan. | 1 | ||||
SECTION 2 Definitions. | 1 | ||||
(a) “Board” | 1 | ||||
(b) “Code” | 1 | ||||
(c) “Committee” | 1 | ||||
(d) “Common Stock” | 1 | ||||
(e) “Company” | 1 | ||||
(f) “Compensation” | 1 | ||||
(g) “Corporate Reorganization” | 1 | ||||
(h) “Eligible Employee” | 2 | ||||
(i) “Exchange Act” | 2 | ||||
(j) “Fair Market Value” | 2 | ||||
(k) “Offering” | 2 | ||||
(l) “Offering Date” | 2 | ||||
(m) “Offering Period” | 2 | ||||
(n) “Participant” | 2 | ||||
(o) “Participating Company” | 2 | ||||
(p) “Plan” | 3 | ||||
(q) “Plan Account” | 3 | ||||
(r) “Purchase Date” | 3 | ||||
(s) “Purchase Period” | 3 | ||||
(t) “Purchase Price” | 3 | ||||
(u) “Subsidiary” | 3 | ||||
(v) “Trading Day” | 3 | ||||
SECTION 3 Administration of the Plan. | 3 | ||||
(a) Administrative Powers and Responsibilities | 3 | ||||
(b) International Administration | 4 | ||||
SECTION 4 Enrollment and Participation. | 4 | ||||
(a) Offering Periods | 4 | ||||
(b) Enrollment | 4 | ||||
(c) Duration of Participation | 5 | ||||
SECTION 5 Employee Contributions. | 5 | ||||
(a) Frequency of Payroll Deductions | 5 | ||||
(b) Amount of Payroll Deductions | 5 | ||||
(c) Changing Withholding Rate | 5 | ||||
(d) Discontinuing Payroll Deductions | 5 | ||||
SECTION 6 Withdrawal from the Plan. | 6 | ||||
(a) Withdrawal | 6 | ||||
(b) Re-enrollment After Withdrawal | 6 | ||||
SECTION 7 Change in Employment Status. | 6 | ||||
(a) Termination of Employment | 6 | ||||
(b) Leave of Absence | 6 | ||||
(c) Death | 6 | ||||
SECTION 8 Plan Accounts and Purchase of Shares. | 6 | ||||
(a) Plan Accounts | 6 | ||||
(b) Purchase Price | 6 | ||||
(c) Number of Shares Purchased | 7 | ||||
(d) Available Shares Insufficient | 7 | ||||
(e) Issuance of Common Stock | 7 | ||||
(f) Unused Cash Balances | 7 | ||||
(g) Stockholder Approval | 7 | ||||
SECTION 9 Limitations on Stock Ownership. | 8 | ||||
(a) Five Percent Limit | 8 | ||||
(b) Dollar Limit | 8 | ||||
SECTION 10 Rights Not Transferable. | 8 | ||||
SECTION 11 No Rights as an Employee | 9 | ||||
SECTION 12 No Rights as a Stockholder. | 9 | ||||
SECTION 13 Securities Law Requirements. | 9 | ||||
SECTION 14 Stock Offered under the Plan. | 9 | ||||
(a) Authorized Shares | 9 | ||||
(b) Anti-dilution Adjustments | 9 | ||||
(c) Reorganizations | 9 | ||||
SECTION 15 Amendment or Discontinuance. | 10 | ||||
SECTION 16 Execution. | 10 | ||||
INTERNATIONAL EMPLOYEE STOCK PURCHASE PLAN | 11 | ||||
SECTION 1 Purpose of the Sub-Plan. | 11 | ||||
SECTION 2 Definitions. | 11 | ||||
(a) “Eligible Employee” | 11 | ||||
(b) “Invitation” | 11 | ||||
(c) “Participant” | 11 | ||||
(d) “Section” | 11 | ||||
SECTION 3 Enrollment and Participation. | 12 | ||||
(a) Offering Periods | 12 | ||||
(b) Enrollment | 12 | ||||
(c) Duration of Participation | 12 | ||||
(d) Dollar Limit | 13 | ||||
SECTION 4 Employee Contributions. | 3 | ||||
(a) Frequency of Payroll Deductions | 3 | ||||
(b) Amount of Payroll Deductions | 3 | ||||
(c) Changing Withholding Rate | 3 | ||||
(d) Discontinuing Payroll Deductions | 4 | ||||
(e) Plan Account | 4 | ||||
SECTION 5 Conversion of Plan Account into U.S. Currency. | 4 | ||||
(a) Conversion to U.S. Dollars | 4 | ||||
(b) Conversion to Local Currency | 4 | ||||
SECTION 6 Miscellaneous | 4 | ||||
(a) Effect of Addenda | 4 | ||||
(b) Effect of Certain Plan Terms | 4 | ||||
(c) No Retention Rights | 5 | ||||
(d) No Guaranty of Gain | 5 | ||||
(e) Waiver | 5 | ||||
(f) Severability | 5 | ||||
SECTION 7 Execution. | 5 | ||||
| Name of Subsidiary | Jurisdiction of Organization | ||||
| ABC Consulting S.A. | Argentina | ||||
| Beijing Jumeng Technology Development Ltd. | China | ||||
| Bin Call Services Joint Stock Company | Türkiye | ||||
| C Automobile Services France | France | ||||
| CCS France | France | ||||
| CGE France | France | ||||
| Chongqing Jumeng Technologies Development Ltd. | China | ||||
| CNX Services Jamaica Limited | Jamaica | ||||
| CNXC CUSTOMER EXPERIENCE SPAIN, S.L. | Spain | ||||
| CNXC Services Curaçao B.V. | Curacao | ||||
| Concentrix (Canada) Limited | Ontario | ||||
| Concentrix (Suzhou) Data Services Co. Ltd. | China | ||||
| Concentrix (Suzhou) Information Consulting Co., Ltd. | China | ||||
| Concentrix Afrique | Morocco | ||||
| Concentrix Agadir | Morocco | ||||
| Concentrix Albania Shpk | Albania | ||||
| Concentrix Angers France | France | ||||
| Concentrix Austria GmbH | Austria | ||||
| Concentrix Benin | Benin | ||||
| Concentrix BH d.o.o. Sarajevo | Bosnia-Herzegovina | ||||
| Concentrix BPO Consulting Peru S.A.C. | Peru | ||||
| Concentrix Brasil Terceirizacao de Processos, Servicos Administrativos e Tecnologia Empresarial Ltda | Brazil | ||||
| Concentrix Business Services UK Limited | England and Wales | ||||
| Concentrix Caen France | France | ||||
| Concentrix Catalyst Canada, Inc. | British Columbia | ||||
| Concentrix Catalyst France | France | ||||
| Concentrix Catalyst FZCO | United Arab Emirates | ||||
| Concentrix Catalyst Holdings Pty. Ltd. | Australia | ||||
| Concentrix Catalyst LTD | United Kingdom | ||||
| Concentrix Catalyst MX Holdings LLC | Delaware | ||||
| Concentrix Catalyst Pty. Ltd. | Australia | ||||
| Concentrix Catalyst Romania S.A. | Romania | ||||
| Concentrix Catalyst Technologies Private Limited | India | ||||
| Concentrix Catalyst Technology Mexico, S.A. de C.V. | Mexico | ||||
| Concentrix Catalyst USA Holdings, LLC | Nevada | ||||
| Concentrix Compiègne France | France | ||||
| Concentrix Conseil France | France | ||||
| Concentrix Contact Center | Morocco | ||||
| Concentrix Costa Rica, S.A. | Costa Rica | ||||
| Concentrix Cote D'Ivoire | Cote D'Ivoire | ||||
| Concentrix CRM Colombia S.A.S | Colombia | ||||
| Concentrix CX Australia Pty. Ltd. | Australia | ||||
| Concentrix CX Colombia S.A.S. | Colombia | ||||
| Concentrix CX France | France | ||||
| Concentrix CX Malaysia SDN. BHD. | Malaysia | ||||
| Concentrix CX Nicaragua S.A. | Nicaragua | ||||
| Concentrix CX Technologies Ltd | Ghana | ||||
| Concentrix CX UK Limited | United Kingdom | ||||
| Concentrix CyberProtect US, Inc. | Delaware | ||||
| Concentrix Czech Republic, s.r.o. | Czech Republic | ||||
| Concentrix d.o.o. Beograd | Serbia | ||||
| Concentrix Daksh Services India Private Limited | India | ||||
| Concentrix Daksh Services Philippines Corporation | Philippines | ||||
| Concentrix Denmark A/S | Denmark | ||||
| Concentrix Digital Services Limited | United Kingdom | ||||
| Concentrix DOOEL Skopje | Republic of North Macedonia | ||||
| Concentrix Düsseldorf GmbH | Germany | ||||
| Concentrix EMEA Financing Center B.V. | Netherlands | ||||
| Concentrix Estonia Oü | Estonia | ||||
| Concentrix Europe Limited | United Kingdom | ||||
| Concentrix Experts Colombia SAS | Colombia | ||||
| Concentrix Fes | Morocco | ||||
| Concentrix Finland OY | Finland | ||||
| Concentrix Fontenay Le Comte France | France | ||||
| Concentrix Frankfurt a. M. GmbH | Germany | ||||
| Concentrix Free Trade Zone, S.A. | Costa Rica | ||||
| Concentrix Germany GmbH | Germany | ||||
| Concentrix Global Services GmbH | Germany | ||||
| Concentrix Global Services Inc. | Delaware | ||||
| Concentrix Global Services Inc. Philippine Branch | Philippines | ||||
| Concentrix Gray France | France | ||||
| Concentrix GRC | Morocco | ||||
| Concentrix Greece Single Member Limited Liability Company | Greece | ||||
| Concentrix Guatemala S.A. | Guatemala | ||||
| Concentrix Health Management Services, Inc. | Philippines | ||||
| Concentrix Healthcare Services LLC | Delaware | ||||
| Concentrix Healthcare Services LLC Philippine Branch | Philippines | ||||
| Concentrix HK Limited | Hong Kong | ||||
| Concentrix Holding Germany GmbH | Germany | ||||
| Concentrix Holding Germany GmbH | Slovenia | ||||
| Concentrix Human Resource Consultancy and Support Services Joint Stock Company | Türkiye | ||||
| Concentrix India Private Limited | India | ||||
| Concentrix International Colombia S.A.S | Colombia | ||||
| Concentrix International Europe B.V. | Netherlands | ||||
| Concentrix International Europe B.V. (Branch) | Dominican Republic | ||||
| Concentrix International GmbH | Germany | ||||
| Concentrix Investment Holdings Singapore 3 Pte.Ltd. | Singapore | ||||
| Concentrix Investments Europe B.V. | Netherlands | ||||
| Concentrix Israel Ltd | Israel | ||||
| Concentrix IT Services Sweden AB | Sweden | ||||
| Concentrix KYC Services | France | ||||
| Concentrix Latvia SIA | Latvia | ||||
| Concentrix Le Workshop Cote D'Ivoire | Cote D'Ivoire | ||||
| Concentrix Legal Services Co., Ltd (Branch- Hochiminh City) | Vietnam | ||||
| Concentrix Legal Services Co., Ltd. | Vietnam | ||||
| Concentrix Lisboa, Unipessoal LDA | Portugal | ||||
| Concentrix Lithuania UAB | Lithuania | ||||
| CONCENTRIX LOGBOX USA INC. | New York | ||||
| Concentrix Madagascar | Madagascar | ||||
| Concentrix Malaysia Sdn. Bhd. | Malaysia | ||||
| Concentrix Management Holding B.V. & Co. KG | Germany | ||||
| Concentrix Management Service (UK) LTD | United Kingdom | ||||
| Concentrix Maroc | Morocco | ||||
| Concentrix Marrakech | Morocco | ||||
| Concentrix Medica Customer Expérience France | France | ||||
| Concentrix Medica France | France | ||||
| Concentrix Medica UK LTD | United Kingdom | ||||
| Concentrix Meknes | Morocco | ||||
| Concentrix Mexico, S. de R.L. de C.V. | Mexico | ||||
| Concentrix Montcau France | France | ||||
| Concentrix Multimedia | Morocco | ||||
| Concentrix Nederland B.V. | Netherlands | ||||
| Concentrix Netherlands CRM Services B.V. | Netherlands | ||||
| Concentrix Netherlands Customer Contact Performance Group B.V. | Netherlands | ||||
| Concentrix Netherlands CX Holding B.V. | Netherlands | ||||
| Concentrix Netherlands Holdco One B.V. | Netherlands | ||||
| Concentrix Netherlands Holdco Three B.V. | Netherlands | ||||
| Concentrix Netherlands Holdco Three B.V. | Netherlands | ||||
| Concentrix Netherlands Holdco Two B.V. | Netherlands | ||||
| Concentrix Netherlands Holding B.V. | Netherlands | ||||
| Concentrix Nicaragua S.A. | Nicaragua | ||||
| Concentrix Norte, Unipessoal LDA | Portugal | ||||
| Concentrix Norway AS | Norway | ||||
| Concentrix Norway Consulting AS | Norway | ||||
| Concentrix O2C Holding | France | ||||
| Concentrix Oeiras, Unipessoal Lda | Portugal | ||||
| Concentrix Payment Services Benelux | Belgium | ||||
| Concentrix Payment Services Deutschland GmbH | Germany | ||||
| Concentrix Payment Services Espana S.A.U | Spain | ||||
| Concentrix Services US, Inc. | Delaware | ||||
| Concentrix Servicios Colombia S.A.S | Colombia | ||||
| Concentrix SFIA - Sucursal em Portugal | Portugal | ||||
| Concentrix SFIA France | France | ||||
| Concentrix Slovakia s.r.o. | Slovakia | ||||
| Concentrix Software Technologies (HK) Limited | Hong Kong | ||||
| Concentrix Solutions Corporation | New York | ||||
| Concentrix Solutions Guatemala S.A. | Guatemala | ||||
| Concentrix South Africa (Pty) Ltd | South Africa | ||||
| Concentrix Spain Business Process Outsourcing, S.L. | Spain | ||||
| Concentrix Spain Holding, S.L. | Spain | ||||
| Concentrix Spain NWE Services, S.L. | Spain | ||||
| Concentrix SREV Bulgaria EOOD | Bulgaria | ||||
| Concentrix SREV Delaware, Inc. | Delaware | ||||
| Concentrix SREV Europe Limited | Ireland | ||||
| Concentrix SREV Europe UK Limited | United Kingdom | ||||
| Concentrix SREV Malaysia SDN. BHD. | Malaysia | ||||
| Concentrix SREV Philippines, Inc. | Philippines | ||||
| Concentrix SREV Singapore Pte. Ltd. | Singapore | ||||
| Concentrix SREV, Inc. | Delaware | ||||
| Concentrix Succursale CI (Ivory Coast Branch) | Cote D'Ivoire | ||||
| Concentrix Succursale Maroc | Morocco | ||||
| Concentrix Succursale Senegal | Senegal | ||||
| Concentrix Sun Portugal Lda | Portugal | ||||
| Concentrix Suriname N.V. | Suriname | ||||
| Concentrix Sweden AB | Sweden | ||||
| Concentrix Technologies (India) Private Limited | India | ||||
| Concentrix Technologies Services (Canada) ULC | Nova Scotia | ||||
| Concentrix Technopolis | Morocco | ||||
| Concentrix TSC UK LTD | United Kingdom | ||||
| Concentrix UK Holdings LTD | United Kingdom | ||||
| Concentrix UK Trading LTD | United Kingdom | ||||
| Concentrix University France | France | ||||
| Concentrix University Maroc | Morocco | ||||
| Concentrix US Holdings, Inc. | Delaware | ||||
| Concentrix Verwaltungs GmbH | Austria | ||||
| Concentrix Vitré France | France | ||||
| Concentrix VN Technologies Services Company Limited | Vietnam | ||||
| Concentrix Wuppertal GmbH | Germany | ||||
| Concentrix Xperts Guatemala S.A. | Guatemala | ||||
| Convergys Customer Management International Inc. - Regional Operating Headquarters | Philippines | ||||
| Convergys Holdings (GB) Limited | United Kingdom | ||||
| Convergys Holdings (UK) Limited | United Kingdom | ||||
| Convergys India Services Private Limited | India | ||||
| Convergys International Inc. | Delaware | ||||
| CTG France | France | ||||
| Dalian Jumeng Information Services Ltd. | China | ||||
| Dalian Jumeng Technologies Development Ltd. | China | ||||
| Direct Medica Iberica S.L. | Spain | ||||
| DMHP Direct Medica Portugal, Lda | Portugal | ||||
| Encore Receivable Management, Inc. (Philippines Branch) | Philippines | ||||
| Encore Receivable Management, Inc (Costa Rica Branch) | Costa Rica | ||||
| Encore Receivable Management, Inc. | Kansas | ||||
| Encore Receivable Management, Inc. (branch in South Africa) | South Africa | ||||
| Encore Receivable Management, Inc. Sucursal Colombia | Colombia | ||||
| eTelecare Philippines, Inc. | Philippines | ||||
| EXQ Service LLC | Kosovo | ||||
| Foshan Jumeng Information Technology Service Co., Ltd. | China | ||||
| Getcom International SA de CV | El Salvador | ||||
| Gobeyond Partners Asia Limited | Hong Kong | ||||
| Grupo Services SA | Brazil | ||||
| Guiyang Jumeng Technology Development Ltd. | China | ||||
| Intervoice Acquisition Subsidiary, Inc. | Nevada | ||||
| Intervoice GmbH | Germany | ||||
| Intervoice GP, Inc. | Nevada | ||||
| Intervoice Limited | United Kingdom | ||||
| Intervoice Limited Partnership | Nevada | ||||
| Intervoice LP, Inc. | Nevada | ||||
| IQ-to-Link GmbH (Kosovo Branch) | Kosovo | ||||
| Japan Concentrix KK | Japan | ||||
| Kayni.com S.A.C. | Peru | ||||
| Les Services Webhelp Inc. | Quebec | ||||
| Marnix French ParentCo S.A.S. | France | ||||
| Marnix Lux S.à r.l. | Luxembourg | ||||
| Marnix S.A.S. | France | ||||
| Netino Madagascar | Madagascar | ||||
| Netino S.A.S. | France | ||||
| Onelink Mexico S.A. de C.V. | Mexico | ||||
| Onelink S.A. de C.V. | El Salvador | ||||
| Onelink Servicios S.A. de C.V. | Mexico | ||||
| OSYRIS LLC | Delaware | ||||
| Patientys S.A.S. | France | ||||
| PT Concentrix Services Indonesia | Indonesia | ||||
| PT Convergys Customer Management Indonesia | Indonesia | ||||
| RH-T SA de CV | El Salvador | ||||
| Righthead GmbH | Germany | ||||
| SAI Digital K.K. | Japan | ||||
| SAI Digital Limited | Hong Kong | ||||
| SAI Digital Limited | Vietnam | ||||
| SAI Digital Limited Korea | Korea, Republic Of | ||||
| SAI Digital PTE LTD | Singapore | ||||
| SAIDIGITAL AGENCY PRIVATE LIMITED | India | ||||
| Sellbytel Group (Branch) | South Africa | ||||
| Sellbytel Group Tunisie S.à r.l | Tunisia | ||||
| Sellbytel Marketing Services India Private Limited | India | ||||
| Services Assessoria Digital Ltda | Brazil | ||||
| Services Tech Experience Inovaçao e technologia em relacionamento Ltda | Brazil | ||||
| SGS Holdings, Inc. | Delaware | ||||
| Shenzhen Shunrong Telecommunication Technologies Ltd | China | ||||
| Sichuan 86Bridge Information Technology Ltd. | China | ||||
| Solvencia S.A.S. | France | ||||
| SPA Concentrix Algerie | Algeria | ||||
| Stream Florida Inc. | Delaware | ||||
| Stream Global Services, Inc. | Delaware | ||||
| Stream Holdings Corporation | Delaware | ||||
| Suzhou Ke Wei Xun Information Services Co., Ltd. | China | ||||
| Teknofix Telecomunication and Information Services Joint Stock Company | Türkiye | ||||
| Tetel SA de CV | El Salvador | ||||
| The Global Email Trustee Limited | United Kingdom | ||||
| Thinkblink Inc. | Philippines | ||||
| Transactel Honduras S.A. de C.V. | Honduras | ||||
| Velami Holdings Corporation | Philippines | ||||
| Vietnam Concentrix Services Company Limited | Vietnam | ||||
| Webhelp Americas LLC | Delaware | ||||
| Webhelp Arabia Telecommunication Company LLC | Saudi Arabia | ||||
| Webhelp Brasil Participaçoes LTDA | Brazil | ||||
| Webhelp Bulgaria EOOD | Bulgaria | ||||
| Webhelp Colombia SAS | Colombia | ||||
| Webhelp Egypt LLC | Egypt | ||||
| Webhelp Enterprise Sales Solutions Italy S.r.l. | Italy | ||||
| Webhelp Japan KK | Japan | ||||
| Webhelp Kosovo L.L.C. | Kosovo | ||||
| Webhelp Mexico, S. de R.L. de C.V. | Mexico | ||||
| Webhelp New Generation Lisbon Unipessoal Lda | Portugal | ||||
| Webhelp Peru S.A.C. | Peru | ||||
| Webhelp Philippines, Inc. | Philippines | ||||
| Webhelp Poland Sp. z o.o. | Poland | ||||
| Webhelp Romania S.R.L. | Romania | ||||
| Webhelp SAS, Sucursal en Espana | Spain | ||||
| Webhelp Sun Holding GmbH | Germany | ||||
| Webhelp USA Group Inc | Delaware | ||||
| Webhelp USA LLC | Delaware | ||||
| Xi'an Jumeng Technologies Development Ltd | China | ||||
| Xperts Nicaragua SA | Nicaragua | ||||
| January 28, 2026 | ||||||||
/s/ Christopher Caldwell | ||||||||
| President and Chief Executive Officer | ||||||||
| January 28, 2026 | ||||||||
/s/ Andre Valentine | ||||||||
| Chief Financial Officer | ||||||||
/s/ Christopher Caldwell | |||||
| Date: January 28, 2026 | Christopher Caldwell President and Chief Executive Officer | ||||
/s/ Andre Valentine | |||||
| Date: January 28, 2026 | Andre Valentine Chief Financial Officer | ||||